Mariëlle Ruijs

1.6k citations

15 papers · 399 indexed · h-index 10

Co-authors: Senno Verhoef Margreet G.E.M. Ausems Anja Wagner Laura J. van’t Veer E. Gómez Neil K. Aaronson Rolf H. Sijmons Liesbeth Spruijt
Topics: Cancer-related Molecular Pathways (10 papers)Epigenetics and DNA Methylation (5 papers)BRCA gene mutations in cancer (4 papers)
Cited by: Oncology Cancer Research Genetics
Journals: Journal of Clinical Oncology PLoS ONE Psycho-Oncology
Partner nations: Netherlands United States Finland

In The Last Decade

Mariëlle Ruijs

15 papers receiving 389 citations

Peers

Countries citing papers authored by Mariëlle Ruijs

Since Specialization

Citations

This map shows the geographic impact of Mariëlle Ruijs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariëlle Ruijs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariëlle Ruijs more than expected).

Fields of papers citing papers by Mariëlle Ruijs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariëlle Ruijs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariëlle Ruijs. The network helps show where Mariëlle Ruijs may publish in the future.

Co-authorship network of co-authors of Mariëlle Ruijs

This figure shows the co-authorship network connecting the top 25 collaborators of Mariëlle Ruijs. A scholar is included among the top collaborators of Mariëlle Ruijs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariëlle Ruijs. Mariëlle Ruijs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics 2023 ·Genetics in Medicine ·Roelof Koster,Luuk J. Schipper,(unknown),Daphne M. van Beek,(unknown),Kris G. Samsom,Efraim H. Rosenberg,Frans B.L. Hogervorst,Paul Roepman,Mirjam C. Boelens,Linda J.W. Bosch,José G. van den Berg,Gerrit A. Meijer,Emile E. Voest,Edwin Cuppen,Mariëlle Ruijs,Tom van Wezel,Lizet van der Kolk,Kim Monkhorst	2
2	Challenges in breast cancer genetic testing. A call for novel forms of multidisciplinary care and long-term evaluation 2022 ·Critical Reviews in Oncology/Hematology ·Fred H. Menko,Kim Monkhorst,Frans B.L. Hogervorst,Efraim H. Rosenberg,Muriel A. Adank,Mariëlle Ruijs,Eveline M. A. Bleiker,Gabe S. Sonke,Nicola S. Russell,Hester S. A. Oldenburg,Lizet E. van der Kolk	6
3	Cumulative risk of skin cancer in patients with Li-Fraumeni syndrome 2020 ·Familial Cancer ·(unknown),(unknown),Mariëlle Ruijs,Gabe S. Sonke,Monique E. van Leerdam,Marianne B. Crijns	5
4	TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort 2019 ·Familial Cancer ·(unknown),Frans B.L. Hogervorst,Mary E. Velthuizen,Mariëlle Ruijs,Klaartje van Engelen,(unknown),Gilles Thomas,Margriet Collée,A M van den Ouweland,Christi J. van Asperen,C. Marleen Kets,Arjen R. Mensenkamp,Edward M. Leter,Marinus J. Blok,M. M. de Jong,Margreet G.E.M. Ausems	22
5	Performance of BRCA1/2 mutation prediction models in male breast cancer patients 2017 ·Clinical Genetics ·Setareh Moghadasi,(unknown),Luc Janssen,(unknown),Mar Rodríguez‐Girondo,Wendy A.G. van Zelst–Stams,Jan C. Oosterwijk,Margreet G.E.M. Ausems,Reinhard Oldenburg,Muriel A. Adank,Eveline W Blom,Mariëlle Ruijs,Theo A.M. van Os,Carolien H. M. van Deurzen,(unknown),(unknown),Juul Wijnen,Maaike P.G. Vreeswijk,Christi J. van Asperen	3
6	Distress in partners of individuals diagnosed with or at high risk of developing tumors due to rare hereditary cancer syndromes 2011 ·Psycho-Oncology ·(unknown),Eveline M. A. Bleiker,Senno Verhoef,Margreet G.E.M. Ausems,Daniëlle Majoor‐Krakauer,Rolf H. Sijmons,Frederik J. Hes,E. Gómez,Theo A.M. van Os,Liesbeth Spruijt,Rob B. van der Luijt,A.M.W. van den Ouweland,Mariëlle Ruijs,Chad M. Gundy,(unknown),Neil K. Aaronson	24
7	Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits 2010 ·Familial Cancer ·(unknown),Eveline M. A. Bleiker,Neil K. Aaronson,Anja Wagner,Rolf H. Sijmons,Margreet G.E.M. Ausems,A. H. J. T. Vriends,Mariëlle Ruijs,Theo A.M. van Os,Liesbeth Spruijt,E. Gómez,Annemieke Cats,(unknown),Senno Verhoef	53
8	Genetic Testing in Li-Fraumeni Syndrome: Uptake and Psychosocial Consequences 2010 ·Journal of Clinical Oncology ·(unknown),Neil K. Aaronson,Anja Wagner,Rolf H. Sijmons,Margreet G.E.M. Ausems,A. H. J. T. Vriends,Mariëlle Ruijs,Theo A.M. van Os,Liesbeth Spruijt,E. Gómez,Irma Kluijt,(unknown),Senno Verhoef,Eveline M. A. Bleiker	75
9	The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype 2009 ·Hereditary Cancer in Clinical Practice ·Mariëlle Ruijs,Annegien Broeks,Fred H. Menko,Margreet G.E.M. Ausems,Anja Wagner,Rogier A. Oldenburg,Hanne Meijers‐Heijboer,Laura J. van’t Veer,Senno Verhoef	29
10	Attitude towards pre-implantation genetic diagnosis for hereditary cancer 2009 ·Familial Cancer ·(unknown),Eveline M. A. Bleiker,Neil K. Aaronson,A. H. J. T. Vriends,Margreet G.E.M. Ausems,M. C. E. Jansweijer,Anja Wagner,Rolf H. Sijmons,Ans van den Ouweland,Rob B. van der Luijt,Liesbeth Spruijt,E. Gómez,Mariëlle Ruijs,Senno Verhoef	40
11	An Information-Theoretic Analysis of Genetics, Gender and Age in Cancer Patients 2008 ·PLoS ONE ·Gurinder S. Atwal,Raúl Rabadán,Guillermina Lozano,Louise C. Strong,Mariëlle Ruijs,Marjanka K. Schmidt,Laura J. van’t Veer,Heli Nevanlinna,Johanna Tommiska,Kristiina Aittomäki,Gaëlle Bougeard,Thierry Frébourg,Arnold J. Levine,Gareth L. Bond	18
12	Two TP53 germline mutations in a classical Li-Fraumeni syndrome family 2007 ·Familial Cancer ·Liselotte P. van Hest,Mariëlle Ruijs,Anja Wagner,Conny A. van der Meer,Senno Verhoef,Laura J. van’t Veer,Hanne Meijers‐Heijboer	8
13	The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li–Fraumeni syndrome and related phenotypes 2006 ·European Journal of Human Genetics ·Mariëlle Ruijs,Marjanka K. Schmidt,Heli Nevanlinna,Johanna Tommiska,Kristiina Aittomäki,(unknown),Senno Verhoef,Laura J. van’t Veer	73
14	Late-Onset Common Cancers in a Kindred with an Arg213Gln TP53 Germline Mutation 2006 ·Familial Cancer ·Mariëlle Ruijs,Senno Verhoef,(unknown),(unknown),Arno Floore,Daphne de Jong,Laura van ‘t Veer,Fred H. Menko	9
15	Atypical progeroid syndrome: An unknown helicase gene defect? 2002 ·American Journal of Medical Genetics Part A ·Mariëlle Ruijs,(unknown),Junko Oshima,K. Madan,Aggie Nieuwint,Cora M. Aalfs	32

About Mariëlle Ruijs

Mariëlle Ruijs is a scholar working on Oncology, Cancer Research and Genetics, having authored 15 papers that have together received 399 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (10 papers), Epigenetics and DNA Methylation (5 papers) and BRCA gene mutations in cancer (4 papers). The work is most often cited by research in Oncology (207 citations), Cancer Research (108 citations) and Genetics (135 citations). Mariëlle Ruijs has collaborated with scholars based in Netherlands, United States and Finland. Frequent co-authors include Senno Verhoef, Margreet G.E.M. Ausems, Anja Wagner, Laura J. van’t Veer, E. Gómez, Neil K. Aaronson, Rolf H. Sijmons, Liesbeth Spruijt, Eveline M. A. Bleiker and A. H. J. T. Vriends. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Psycho-Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact